Dna X (SONM) EBIAT (2018 - 2025)
Historic EBIAT for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to -$4.8 million.
- Dna X's EBIAT fell 8921.18% to -$4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$33.4 million, marking a year-over-year decrease of 14937.63%. This contributed to the annual value of -$33.6 million for FY2024, which is 3728666.67% down from last year.
- Per Dna X's latest filing, its EBIAT stood at -$4.8 million for Q3 2025, which was down 8921.18% from -$7.5 million recorded in Q2 2025.
- Dna X's 5-year EBIAT high stood at $527000.0 for Q3 2023, and its period low was -$21.6 million during Q4 2024.
- For the 5-year period, Dna X's EBIAT averaged around -$5.2 million, with its median value being -$4.2 million (2022).
- Its EBIAT has fluctuated over the past 5 years, first soared by 13277.36% in 2023, then tumbled by 149748.71% in 2024.
- Over the past 5 years, Dna X's EBIAT (Quarter) stood at -$11.7 million in 2021, then soared by 91.11% to -$1.0 million in 2022, then decreased by 29.85% to -$1.4 million in 2023, then tumbled by 1497.49% to -$21.6 million in 2024, then soared by 78.01% to -$4.8 million in 2025.
- Its last three reported values are -$4.8 million in Q3 2025, -$7.5 million for Q2 2025, and $458000.0 during Q1 2025.